O
86.79
-1.48 (-1.68%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Oruka Therapeutics, Inc. | Mixed | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | NA |
| Insider Activity | 0.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.5 |
| Average | -0.13 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 86.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Remedium Capital Partners, Llc | 31 Mar 2026 | 1,565,661 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FAIRMOUNT FUNDS MANAGEMENT LLC | 93.29 | 93.29 | 0 | 0 |
| SANDLER LAURA LEE | - | 93.29 | -5,000 | -466,450 |
| Aggregate Net Quantity | -5,000 | |||
| Aggregate Net Value ($) | -466,450 | |||
| Aggregate Avg. Buy ($) | 93.29 | |||
| Aggregate Avg. Sell ($) | 93.29 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SANDLER LAURA LEE | Officer | 01 Jul 2026 | Automatic sell (-) | 5,000 | 93.29 | 466,450 |
| SANDLER LAURA LEE | Officer | 01 Jul 2026 | Option execute | 5,000 | - | - |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 01 Jul 2026 | Acquired (+) | 3,553,410 | 93.29 | 331,497,619 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 01 Jul 2026 | Sell (-) | 3,553,410 | 93.29 | 331,497,619 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |